Qumas.com

Burixafor is a potent and selective chemokine CXCR4 antagonist developed by TaiGen Biotechnology (www.taigenbiotech.com.tw). The SDF1/CXCR4 pathway plays key roles in homing and mobilization of hematopoietic stem cells and endothelial progenitor cells...

World Vaccine Congress Names “Best CMO” At its annual meeting in Washington, DC, this past March, the World Vaccine Congress named Paragon Bioservices, Inc., as the “Best Contract Manufacturing Organization” (CMO) for 2016. The annual Vaccine Industry...

Dates/times: Thursday, June 23 2016 at 09:00 PM (Get Tickets) Location: Courtyard Seattle Sea-Tac Area 16038 W Valley Hwy Tukwila, WA 98188 Event Description: Course "How FDA Trains Its Investigators to Review Sub-Systems for State of Compliance...

According to the report, global demand for active pharmaceutical ingredient market was valued at USD 148.22 billion in 2015, is expected to reach USD 213.84 billion in 2021 and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021. Zion Market...

By: Howard Sklamberg and Mary Lou Valdez Howard Sklamberg, FDA’s Deputy Commissioner for Global Regulatory Operations and Policy It’s simple but true: relentless global commerce and interaction demand a globalized FDA. That’s why we’ve made determined...